Published on : Jan 10, 2018
Albany, New York, January 10, 2018: Market Research Hub (MRH) has incorporated a first-hand publication in its database named ‘Diabetes Drugs Market.’ The research report on the global market for diabetes drugs analyzes the present and future market scenario of the worldwide market. The positive regulatory scenario for introduction of new drugs, increase in public and private funding for diabetes medicines, increasing commonness of diabetes has led to the growth of the global market for diabetes drugs. Rapid rise in elderly population around the world and increasing incidence as well as commonness of diabetes such as Type 1 diabetes and Type 2 diabetes are aspects likely to increase the growth in revenue of the global market for diabetes drugs over the period of forecast.
Global Diabetes Drugs Market: Segmental Analysis & Regional Overview
The research study categorizes the global market for diabetes drugs by disease type, therapy, channel of distribution, and region.
On the basis of disease type, this report segregates the global diabetes drugs market into Impaired Glucose Tolerance and Impaired Fasting Glycaemia, Type 1 Diabetes, Gestational Diabetes, and Type 2 Diabetes. Based on channel of distribution, the study categorizes the diabetes drugs market into online pharmacies, hospital pharmacies and retail pharmacies. According to therapy, the research study divides the international diabetes drugs market into Sodium glucose co-transporter 2 (SGLT2) inhibitors, Glucagon-like peptide-1 (GLP-1) agonist, Insulin, and Dipeptidyl-peptidase-4 (DPP-4) inhibitors.
The insulin segment dominated the global market in terms of revenue share in 2016. An increasing demand and need for insulin has led to an increase in the prices of insulin. Insulin is anticipated to dominate the diabetes drugs market during the assessment period. Sodium glucose co-transporter 2 is expected to grow over the period of assessment owing to exclusivity and patents. The other drug class segment is expected to rise throughout the period of forecast from 2017 to 2025. On the basis of region, the report bifurcates the worldwide market for diabetes drugs market into Asia Pacific, North America, the Middle East & Africa, Europe and Latin America. The report presents market attractiveness index as well as insights on companies to help readers understand the current landscape of the diabetes drugs market around the world. This report also showcases the regulations and polices along with the key market findings and market estimates across individual regional markets.
Global Diabetes Drugs Market: Key Player Insights
The final portion of the research report offers a dashboard view of the competitive scenario present in the global market to help readers acquire deep insights on the competition existing in the worldwide diabetes drugs market. This section of the report profiles key companies operating in the diabetes drugs market. The research report profiles prominent companies on the basis of various aspects such as financial overview, product portfolios, SWOT analysis, key strategies, as well as current developments in the diabetes drugs market across the globe. Some of the prominent companies featured in the report are as Takeda Pharmaceutical Company Limited, Novo Nordisk A/S, Eli Lilly and Company, Merck & Co., Inc., Johnson & Johnson, Novartis AG, Bayer AG, Boehringer Ingelheim GmbH, and Sanofi.
Request a Sample with TOC in a PDF format : https://www.marketresearchhub.com/enquiry.php?type=S&repid=1461379
About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
For Enquiries, Call :
+1-800-998-4852US Toll Free
Email : firstname.lastname@example.org